news.internacionalesnoticias.netCorrespondents · Reports · Analysis
CORRESPONDENT REPORTTechnology

Coroner Links Richard Norton’s Death to Unapproved Peptides, Urges TGA Review

Published
Oct 28, 2026
Desk
Technology
Views
1,859

A coroner found unapproved peptides contributed to actor Richard Norton’s death and recommended the TGA review their risks and restrictions.

A coroner’s finding that unapproved peptides triggered actor Richard Norton’s fatal cardiac arrest has put the safety and oversight of these products under renewed scrutiny. The Therapeutic Goods Administration (TGA) has been asked to review the benefits and risks of CJC1295 and Ipamorelin and consider whether tighter restrictions are needed.

Norton, 75, died at Melbourne’s Alfred Hospital on March 30, 2025. Coroner David Ryan found that complications from the injected peptides led to his collapse and cardiac arrest. His death is believed to be Australia’s first confirmed fatality linked to unapproved peptide use.

The findings also record that Norton had been taking more than the prescribed amount. A nurse at the prescribing clinic learned he was administering double the dose and advised him to return to the prescribed amount the following week. Hours after that conversation, Norton became unresponsive after an injection.

Experimental treatment with a documented dose concern

Norton had approached medical practitioner Dr Jerzy Muchnicki because he was interested in peptide therapy. He had asthma, osteoarthritis and a history of surgery on both shoulders. He told the doctor that a previous practitioner had prescribed peptides for fatigue, slow physical recovery, shoulder pain and loss of lean muscle mass.

According to the coroner’s report, Muchnicki reviewed Norton’s medical history and discussed the experimental nature of the treatment, its potential risks and the lack of TGA-approved alternatives. Norton signed an informed consent form covering the treatment, its benefits and risks. The doctor also arranged blood tests to establish baseline health measures and check for conditions that could affect treatment decisions.

CJC1295 and Ipamorelin were prescribed as injections and compounded for Norton by a licensed pharmacy in Queensland. In the days before his death, Norton told the doctor he felt good and that the therapy was easing his symptoms. The coroner found, however, that Norton had taken doses above the amount prescribed.

Ryan said the death was “triggered by” Norton’s injection of the products. His recommendation asks the TGA to assess the therapeutic benefits alongside the safety risks, then consider whether further limits on their use are warranted. The ABC has contacted Muchnicki for comment.

Medical review found gaps in clinical records

The Australian Health Practitioner Regulation Agency received a notification raising concerns about Norton’s treatment, prompting an investigation by the Medical Board of Australia. The board sought an assessment from Clinical Professor Alistair Vickery, who concluded there was insufficient evidence that CJC1295 and Ipamorelin were safe, effective or beneficial for human use.

Vickery judged that the clinical care Muchnicki provided met a reasonably expected standard, taking into account the doctor’s training and experience, Norton’s written consent and his previous peptide use without reported adverse effects. But he described the clinical notes as “sparse, inadequate and perfunctory” and said the doctor’s performance fell below the expected standard in record keeping.

The board’s investigation said Muchnicki acknowledged the criticisms, accepted responsibility and apologised for errors in judgment and shortcomings in his records. He also expressed sorrow for the impact on Norton and his family, and said he had hired an educator for individual guidance on clinical records and management.

In July, the Medical Board found that Muchnicki’s practice “is or may be unsatisfactory”. It issued a caution and imposed conditions, but decided regulatory action beyond those measures wasn’t warranted.

TGA continues to assess peptide risks

The coroner’s report noted that medical practitioners have several pathways for accessing unapproved peptides. After the finding, the TGA said the products had not been assessed for safety, quality or effectiveness and reiterated its warnings to consumers. It also said it had communicated the risks to health practitioners.

The regulator said it was continuing to assess the risks and considering whether further regulatory or other measures might be appropriate. Ryan’s recommendation gives that review a specific focus: the evidence for CJC1295 and Ipamorelin, and whether their use should face additional restrictions.

Richard Norton sits on a bench with the sun setting behind him

Richard Norton was an experienced martial artist who worked in film and television as an actor, stuntman and instructor. (Instagram)

Black and white image of two men with their arms around each others' shoulders holding a fist up to the camera

Action star Chuck Norris paid tribute to his friend Richard Norton in an Instagram post. (Instagram: Chuck Norris)

A syringe sits on top of a vile

Richard Norton collapsed and suffered cardiac arrest after injecting unapproved peptides. (ABC News)

The case leaves a concrete question for the TGA: whether current access pathways and warnings are sufficient when the products lack established evidence for human use. Its review will determine what, if any, further steps follow the coroner’s recommendation.

Source: Caitlyn Gribbin and Rachel Carbonell · www.abc.net.au

Discussion

Sign in to join the discussion.